These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2711826)

  • 1. Electrophoretic immunoblotting analysis of anti-thymus microsome antibodies in patients with myasthenia gravis.
    Hazama T; Takahashi M; Ueno S; Tarui S
    Acta Neurol Scand; 1989 Feb; 79(2):88-96. PubMed ID: 2711826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymus and myasthenia gravis. Review of 200 cases, with experimental studies on anti-muscle antibodies and lymphocyte function.
    Kano S; Takaku F; Uono M
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):420-7. PubMed ID: 5170455
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE; Aarli JA; Matre R
    Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.
    Behan WM; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1975 Nov; 38(11):1039-47. PubMed ID: 1206412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to thymic epithelial cells in myasthenia gravis.
    Safar D; Aimé C; Cohen-Kaminsky S; Berrih-Aknin S
    J Neuroimmunol; 1991 Dec; 35(1-3):101-10. PubMed ID: 1720131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
    Mittag T; Kornfeld P; Tormay A; Woo C
    N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle.
    Aarli JA
    Clin Exp Immunol; 1972 Mar; 10(3):453-61. PubMed ID: 4624498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell sensitizing antibodies in myasthenia gravis.
    Schwartz J; Eyquem A; Vardinon N
    Immunol Commun; 1975; 4(3):243-50. PubMed ID: 809349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.
    Williams CL; Lennon VA
    J Exp Med; 1986 Oct; 164(4):1043-59. PubMed ID: 3020150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunofluorescence studies in myasthenia].
    Slomkowska H
    Neurol Neurochir Pol; 1972; 6(2):205-10. PubMed ID: 4555306
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and reactivity patterns of skeletal and heart (SH) reactive autoantibodies in the sera of patients with myasthenia gravis.
    Connor RI; Lefvert AK; Benes SC; Lang RW
    J Neuroimmunol; 1990 Feb; 26(2):147-57. PubMed ID: 2298883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis.
    Vincent A; Scadding GK; Thomas HC; Newsom-Davis J
    Lancet; 1978 Feb; 1(8059):305-7. PubMed ID: 75339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.
    Vrolix K; Niks EH; Le Panse R; van Ostaijen-Ten Dam MM; Muris AH; Jol-van der Zijde CM; van Tol MJ; Losen M; Molenaar PC; van Zoelen EJ; Berrih-Aknin S; De Baets MH; Verschuuren JJ; Martínez-Martínez P
    J Neuroimmunol; 2011 Mar; 232(1-2):158-65. PubMed ID: 21168922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
    Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
    Aarli JA; Stefansson K; Marton LS; Wollmann RL
    Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.
    Aharonov A; Tarrab-Hazdai R; Abramsky O; Fuchs S
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1456-9. PubMed ID: 1055418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.